Dr. Reddy's clarifies a news item, confirming it has not yet received Health Canada approval for its Semaglutide Injection.
The company received Drug Identification Numbers (DINs) for the product from Health Canada on April 22, 2026.
The disclosure was triggered by material price movement in the company's shares on April 23, 2026.